Stocks and Investing
by (remove) : Geoff Meacham
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Geoff Meacham
RSSJSONXMLCSV
Tue, September 17, 2024
Wed, September 11, 2024
Mon, August 19, 2024
Wed, August 7, 2024
Tue, June 25, 2024
Fri, May 10, 2024
Fri, April 12, 2024
Wed, March 13, 2024
Wed, January 3, 2024
Wed, December 27, 2023
Wed, October 11, 2023
Fri, September 8, 2023
Tue, August 15, 2023
Fri, July 28, 2023
Fri, July 21, 2023
Thu, July 20, 2023
Thu, May 4, 2023
Fri, April 21, 2023
Thu, January 5, 2023
Wed, December 14, 2022
Mon, December 5, 2022
Tue, June 21, 2022
Fri, April 22, 2022
Mon, March 28, 2022
Thu, March 17, 2022
Thu, February 3, 2022
Fri, January 21, 2022
Wed, January 5, 2022
Thu, December 23, 2021

Geoff Meacham Maintained (BMRN) at Strong Buy with Decreased Target to $115 on, Sep 17th, 2024


Published on 2024-10-28 14:19:20 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of B of A Securities, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Decreased Target from $130 to $115 on, Sep 17th, 2024.

Geoff has made no other calls on BMRN in the last 4 months.



There are 8 other peers that have a rating on BMRN. Out of the 8 peers that are also analyzing BMRN, 2 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold and Held Target at $93 on, Friday, September 13th, 2024
  • Joel Beatty of "Baird" Downgraded from Buy to Hold and Decreased Target to $72 on, Friday, May 17th, 2024


These are the ratings of the 6 analyists that currently disagree with Geoff


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
  • Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $110 on, Tuesday, August 6th, 2024
  • Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024
Contributing Sources